Table 1 Correlation between circKIF20B expression and clinicopathological characteristics in NSCLC patients (n = 85)
Characteristic | circKIF20B expression level(Cancer/Normal) | P-value | |
|---|---|---|---|
Low | High | ||
n | 43 | 42 | Â |
Gender, n (%) | Â | Â | 0.448 |
Female | 19 (22.4%) | 23 (27.1%) | Â |
Male | 24 (28.2%) | 19 (22.4%) | Â |
Histological type, n (%) | Â | Â | 0.789 |
Adenocarcinomas | 36 (42.4%) | 37 (43.5%) | Â |
Squamous cell carcinoma | 7 (8.2%) | 5 (5.9%) | Â |
Smoking status, n (%) | Â | Â | 0.845 |
No | 32 (37.6%) | 33 (38.8%) | Â |
Yes | 11 (12.9%) | 9 (10.6%) | Â |
Tumor size, n (%) | Â | Â | 0.012* |
> 3 | 19 (22.4%) | 7 (8.2%) |  |
≤ 3 | 24 (28.2%) | 35 (41.2%) |  |
Lymph node metastasis, n (%) | Â | Â | 0.116 |
No | 31 (36.5%) | 37 (43.5%) | Â |
Yes | 12 (14.1%) | 5 (5.9%) | Â |
Metastasis, n (%) | Â | Â | 1.000 |
No | 39 (45.9%) | 38 (44.7%) | Â |
Yes | 4 (4.7%) | 4 (4.7%) | Â |
Pathologic stage, n (%) | Â | Â | 0.020* |
I-II | 29 (34.1%) | 38 (44.7%) | Â |
III-IV | 14 (16.5%) | 4 (4.7%) | Â |
Differentiation, n (%) | Â | Â | 0.030* |
Poor | 21 (24.7%) | 10 (11.8%) | Â |
well and moderate | 22 (25.9%) | 32 (37.6%) | Â |
Age, mean ± SD | 60.37 ± 9.93 | 60.74 ± 11.55 | 0.876 |